2011, Number S1
<< Back Next >>
Rev Mex Anest 2011; 34 (S1)
Outcomes and neuromuscular blockade in cardiac anesthesia
Pérez-Martínez NA
Language: Spanish
References: 10
Page: 23-25
PDF size: 441.23 Kb.
ABSTRACT
No abstract
REFERENCES
Practice Guidelines for Postanesthetic Care: A report by the American Society of Anesthesiologists Task Force on Postanesthetic Care. Anestesiology 2002;96:742–52.
Murphy GS. The use of neuromuscular blocking drugs in adult cardiac surgery: results of a national postal survey. Anesth Analg 2002;95:1534-9.
Mohamed N, Aaron FK. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010;111:110-119.
Eriksson LI. Evidence-based practice and neuromuscular monitoring: It’s time for routine quantitative assessment. Anesthesiology 2003;98:1037–9.
Borja FQG. Monitorización en anestesia, cuidados críticos y medicina de urgencias. Monitorización de la relajación muscular. Elsevier Madrid España 2004;28:445-459.
Glenn S, Murphy GS, Szokol JW. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology 2008;109:389–98.
Cammu G. How rational is muscle relaxation during cardiac surgery? Acta Anaesthesiol Belg 2007;58:7-14.
Lemson J. The effect of neuromuscular blockade on oxygen consumption in sedated and mechanically ventilated pediatric patients after cardiac surgery. Intensive Care Med 2008;34:2268-72.
Glenn S, Murphy GS, Sorin JB. Residual Neuromuscular Block: Lessons Unlearned. Part I: Definitions, Incidence, and Adverse Physiologic Effects of Residual Neuromuscular Block. Anesth Analg 2010;111:120-128.
Glenn S, Murphy GS, Sorin JB. Residual Neuromuscular Block: Lessons Unlearned. Part II: Methods to Reduce the Risk of Residual Weakness. Anesth Analg 2010;111:129-140.
Full text